The treatment of the abovementioned cancer cells with the combination of 6-AN as a G6PD inhibitor and cisplatin resulted in sensitization of the cells to cisplatin and reduced cell viability in comparison to cisplatin monotherapy [176,185,186,187,188]. This evidence concerns the gene G6PD and cancer.